GENERAL CE CONFERENCE
July 20, 2024

SATURDAY, JULY 20, 2024

Validation and Counseling of Prescriptions for Controlled Substance and Opioids

8:00-10:00am 

Joseph Cammilleri, PharmD, BCACP, CPE, Ambulatory Care Clinical Pharmacist, Pain Management, PGY2 Pain/Palliative Care Program Director, UF Health.

Upon completion of this activity, pharmacists will be able to: Describe how to ensure access to controlled substances for all patients with a valid prescription; Use the Prescription Drug Monitoring Program’s Database; Assess prescriptions for appropriate therapeutic value; Detect prescriptions that are not based on a legitimate medical purpose; Discuss the laws and rules related to the prescribing and dispensing of controlled substances; Discuss proper patient storage and disposal of controlled substances; Discuss protocols for addressing and resolving problems recognized during the drug utilization review; Provide education on section 381.887, F.S., emergency treatment for suspected opioid overdoses and on the State Surgeon General’s Statewide Standing Order for Naloxone; Counsel patients with opioid prescriptions; Provide available treatment resources for opioid physical dependence, addiction, misuse, or abuse. 

UAN: 0675-0000-24-018-L08-P*

Management of HIV AIDS                                                     

10:15-11:15am 
Briana Journee, PharmD, MBA, CPh, AAHIVP, Medical Science Liaison, ViiV Healthcare

Upon completion of this activity, pharmacists will be able to: Identify current modes of transmission of HIV and prevention strategies; Describe the epidemiology of HIV and the importance of infection control procedures; Distinguish the various therapeutic agents used to treat HIV AIDS; List complications associated with HIV/AIDS; State Florida law on HIV/AIDS and its impact on testing, reporting, confidentiality, procedures for pregnant women and partner notification; Identify the pharmacist role in providing care for HIV infected patients.

UAN: 0675-0000-24-019-L02-P

Mitigation and Prevention of Medication Errors in Pharmacy Practice

11:30-1:30pm 
Norman P. Tomaka, BS Pharm, MS, CPh, FAPhA, Clinical Consultant Pharmacist, Consultant Pharmacy Services

Upon completion of this activity, pharmacists will be able to:  Recognize statutory responsibilities that foster ongoing pharmacy regulatory compliance; Recognize recurring medication errors; Describe quality improvement regulations for pharmacies licensed in Florida; Define elements of a proactive Continuous Quality Improvement process that promotes ongoing quality; Discuss the use of Root Cause Analysis (RCA) to enhance quality pharmacy services and prevent errors; Describe the implementation of an action plan to improve overall pharmacy practice quality and mitigate medication errors; Demonstrate enactment of procedures that promote ongoing patient safety in pharmacy practice.

UAN: 0675-0000-24-020-L05-P